Lipidor
0,303
SEK
+0,66 %
Mindre end 1K følgere
LIPI
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
+0,66%
+15,65%
-5,31%
+42,25%
+125,28%
+413,32%
-80,69%
-89,43%
-82,86%
Lipidor is a pharmaceutical company. The company works with research and development in the preclinical and clinical phases. The largest business is established in the development of pharmaceuticals that are further used for the treatment of various skin diseases. Examples of diseases that are treated include psoriasis, various skin infections, and atopic dermatitis. The head office is located in Solna.
Læs mereMarkedsværdi
246,46 mio. SEK
Aktieomsætning
1,59 mio. SEK
Omsætning
10 t
EBIT %
-142.100 %
P/E
-
Udbytteafkast, %
-
Finanskalender
3.6
2025
Generalforsamling '25
28.8
2025
Delårsrapport Q2'25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Lipidor announces all patients enrolled in ongoing Phase III study
Lipidor AB (publ) publishes year-end report for 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools